AKTX
Akari Therapeutics

8,645
Mkt Cap
$24.13M
Volume
82,483.00
52W High
$3.15
52W Low
$0.5714
PE Ratio
-0.11
AKTX Fundamentals
Price
$0.74
Prev Close
$0.739
Open
$0.7389
50D MA
$0.8711
Beta
0.40
Avg. Volume
475,561.43
P/B
0.94
Rev/Employee
$0.00
Loading...
Loading...
Akari Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Its lead product candidate, Nomacopan, is a second-generation complement inhibitor. The company was founded on October 7, 2004 and is headquartered in Tampa, FL.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
9

Frequently Asked Questions

What is Market Cap of Akari Therapeutics Plc - ADR?
What is the 52-week high for Akari Therapeutics Plc - ADR?
What is the 52-week low for Akari Therapeutics Plc - ADR?
What is Akari Therapeutics Plc - ADR stock price today?
What was Akari Therapeutics Plc - ADR stock price yesterday?
What is the PE ratio of Akari Therapeutics Plc - ADR?
What is the Price-to-Book ratio of Akari Therapeutics Plc - ADR?
What is the 50-day moving average of Akari Therapeutics Plc - ADR?
How many employess does Akari Therapeutics Plc - ADR has?

Latest AKTX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.